These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 23939307)
1. Interaction between α-synuclein and tau genotypes and the progression of Parkinson's disease. Huang Y; Rowe DB; Halliday GM J Parkinsons Dis; 2011; 1(3):271-6. PubMed ID: 23939307 [TBL] [Abstract][Full Text] [Related]
2. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease. Mamah CE; Lesnick TG; Lincoln SJ; Strain KJ; de Andrade M; Bower JH; Ahlskog JE; Rocca WA; Farrer MJ; Maraganore DM Ann Neurol; 2005 Mar; 57(3):439-43. PubMed ID: 15732111 [TBL] [Abstract][Full Text] [Related]
3. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease. Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090 [TBL] [Abstract][Full Text] [Related]
4. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians. Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998 [TBL] [Abstract][Full Text] [Related]
5. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset. Hadjigeorgiou GM; Xiromerisiou G; Gourbali V; Aggelakis K; Scarmeas N; Papadimitriou A; Singleton A Mov Disord; 2006 Apr; 21(4):534-9. PubMed ID: 16250025 [TBL] [Abstract][Full Text] [Related]
6. Lack of interaction of SNCA and MAPT genotypes in Parkinson's disease. Botta-Orfila T; Ezquerra M; Ríos J; Fernández-Santiago R; Cervantes S; Samaranch L; Pastor P; Martí MJ; Muñoz E; Valldeoriola F; Aguilar M; Calopa M; Hernández-Vara J; Tolosa E Eur J Neurol; 2011 Mar; 18(3):e32. PubMed ID: 21054681 [No Abstract] [Full Text] [Related]
7. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease. Mellick GD; Maraganore DM; Silburn PA Neurosci Lett; 2005 Feb; 375(2):112-6. PubMed ID: 15670652 [TBL] [Abstract][Full Text] [Related]
8. MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies. Colom-Cadena M; Gelpi E; Martí MJ; Charif S; Dols-Icardo O; Blesa R; Clarimón J; Lleó A Neurobiol Aging; 2013 Mar; 34(3):936-42. PubMed ID: 22819391 [TBL] [Abstract][Full Text] [Related]
14. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease. Winkler S; König IR; Lohmann-Hedrich K; Vieregge P; Kostic V; Klein C Eur J Hum Genet; 2007 Nov; 15(11):1163-8. PubMed ID: 17637803 [TBL] [Abstract][Full Text] [Related]
15. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain. Fuchs J; Tichopad A; Golub Y; Munz M; Schweitzer KJ; Wolf B; Berg D; Mueller JC; Gasser T FASEB J; 2008 May; 22(5):1327-34. PubMed ID: 18162487 [TBL] [Abstract][Full Text] [Related]
16. Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease. Ai SX; Xu Q; Hu YC; Song CY; Guo JF; Shen L; Wang CR; Yu RL; Yan XX; Tang BS J Neurol Sci; 2014 Feb; 337(1-2):123-8. PubMed ID: 24326201 [TBL] [Abstract][Full Text] [Related]
17. Exploring gene-environment interactions in Parkinson's disease. McCulloch CC; Kay DM; Factor SA; Samii A; Nutt JG; Higgins DS; Griffith A; Roberts JW; Leis BC; Montimurro JS; Zabetian CP; Payami H Hum Genet; 2008 Apr; 123(3):257-65. PubMed ID: 18210157 [TBL] [Abstract][Full Text] [Related]
18. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease. Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000 [TBL] [Abstract][Full Text] [Related]
19. Tau protein: relevance to Parkinson's disease. Lei P; Ayton S; Finkelstein DI; Adlard PA; Masters CL; Bush AI Int J Biochem Cell Biol; 2010 Nov; 42(11):1775-8. PubMed ID: 20678581 [TBL] [Abstract][Full Text] [Related]
20. Tau haplotypes regulate transcription and are associated with Parkinson's disease. Kwok JB; Teber ET; Loy C; Hallupp M; Nicholson G; Mellick GD; Buchanan DD; Silburn PA; Schofield PR Ann Neurol; 2004 Mar; 55(3):329-34. PubMed ID: 14991810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]